These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7136218)

  • 41. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
    Valera JM; Smok G; Márquez S; Poniachik J; Brahm J
    Gastroenterol Hepatol; 2011 Jan; 34(1):10-5. PubMed ID: 21194803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers.
    Uribe M; Casian C; Rojas S; Sierra JG; Go VL
    Gastroenterology; 1981 Apr; 80(4):661-5. PubMed ID: 7202937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis.
    Cuarterolo ML; Ciocca ME; López SI; de Dávila MT; Alvarez F
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):145-9. PubMed ID: 21029789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention of hepatitis B by passive immunization of children with chronic hematologic disease immunoglobulin].
    Rokicka-Milewska R; Kacperska E; Moraczewska Z; Jackowska T; Seyfried H
    Wiad Lek; 1990 Jul; 43(13):639-44. PubMed ID: 2256325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunosuppressive therapy in liver diseases].
    Pelikán V; Seidlová V
    Cesk Gastroenterol Vyz; 1971 Oct; 25(7):321-2. PubMed ID: 5119853
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bile acid therapy; new hope for patients with chronic liver diseases].
    van Berge Henegouwen GP; van Erpecum KJ
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):696-700. PubMed ID: 2038392
    [No Abstract]   [Full Text] [Related]  

  • 48. [Transmission of the hepatitis virus from the mother to her fetus or her newborn infant. Current possibilities of prevention].
    Brossard Y
    Sem Hop; 1983 Jan; 59(4):267-76. PubMed ID: 6301058
    [No Abstract]   [Full Text] [Related]  

  • 49. Circulating thyroxine in chronic active liver disease.
    Barzilai DC; Soloway RD; Summerskill WH; Schoenfield LJ
    Isr J Med Sci; 1974 Nov; 10(11):1405-14. PubMed ID: 4443216
    [No Abstract]   [Full Text] [Related]  

  • 50. [Autoimmune hepatitis in children].
    Lachaux A
    Pediatrie; 1992; 47(10):671-5. PubMed ID: 1337590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [What can be said against the management of HBsAg-positive chronic hepatitis using steroids or immunosuppressive agents?].
    Strohmeyer G; Thier W
    Internist (Berl); 1979 Apr; 20(4):188-92. PubMed ID: 374303
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience with immunosuppressive therapy in chronic aggressive hepatitis].
    Shimelpfenig V; Vagner K; Toier D; Shnaider G; Khekht A; Shimelpfenig R
    Vutr Boles; 1972; 11(3):120-3. PubMed ID: 4679965
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
    Strasser SI; Shulman HM; Flowers ME; Reddy R; Margolis DA; Prumbaum M; Seropian SE; McDonald GB
    Hepatology; 2000 Dec; 32(6):1265-71. PubMed ID: 11093733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatment.
    Salerno F; Tornaghi G; Cappellini MD; Fargion S; Fiorelli G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:272. PubMed ID: 4851922
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppression as adjuvant therapy for biliary atresia.
    Dillon PW; Owings E; Cilley R; Field D; Curnow A; Georgeson K
    J Pediatr Surg; 2001 Jan; 36(1):80-5. PubMed ID: 11150442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunosuppressive treatment in liver diseases].
    Ritland S
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):839-40. PubMed ID: 6879519
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
    Gabriele C; Gabriele S; Bandiermonte Z
    Minerva Pediatr; 1971 Apr; 23(16):725-32. PubMed ID: 5555704
    [No Abstract]   [Full Text] [Related]  

  • 60. [Autoimmune hepatitis and pregnancy: about a patient's three consecutive pregnancies].
    Rivoire C; Houlle C; Bonnin M; Cotte B; Bolandard F; Nohuz E; Jardon K; Rabischong B; Canis M; Mage G
    Gynecol Obstet Fertil; 2008 Mar; 36(3):299-305. PubMed ID: 18313968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.